Search results
Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now
Zacks via Yahoo Finance· 2 days agoWhat’s Hurting the Stock? Cencora operates in a highly competitive pharmaceutical distribution and...
Insider Sale at Madrigal Pharmaceuticals Inc (MDGL): Senior VP, Chief Pharmaceutical ... By...
Investing.com· 5 days agoOn May 21, 2024, Robert Waltermire, Senior Vice President and Chief Pharmaceutical Development...
Insider Sale at Madrigal Pharmaceuticals Inc (MDGL): Senior VP, Chief Pharmaceutical ...
GuruFocus.com via Yahoo Finance· 5 days agoOn May 21, 2024, Robert Waltermire, Senior Vice President and Chief Pharmaceutical Development...
Eli Lilly (LLY) to Ramp Up Indiana Site for Mounjaro, Zepbound
Zacks via Yahoo Finance· 2 days agoSince 2020, Eli Lilly (LLY) has committed more than $18 billion to building new manufacturing sites...
Eupraxia Pharmaceuticals Announces Expansion of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment...
FOX21 Colorado Springs· 6 days agoEupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology ...
Stellantis Vehicles Are Piling Up at Car Dealerships - What’s News - WSJ Podcasts
The Wall Street Journal· 5 days agoPierre Bienaimé: Eli Lilly announces the biggest manufacturing investment in its history, and...
Private Equity Is Bad for Your Health
Bloomberg· 7 days agoLisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry. Previously, she was executive editor of...
How Much Upside is Left in Agios Pharmaceuticals (AGIO)? Wall Street Analysts Think 26.43%
Zacks· 5 days agoFree Report) have gained 3.2% over the past four weeks to close the last trading session at $32.69, but there could still be a solid upside left in the stock if short-term price targets of Wall ...
Insider Sale at Madrigal Pharmaceuticals Inc (MDGL): Senior VP,
Guru Focus· 5 days agoThe transaction was reported in a recent SEC Filing. Following this sale, the insider now owns 5,500 shares of Madrigal Pharmaceuticals Inc. Madrigal Pharmaceuticals ...
How Much Upside is Left in Agios Pharmaceuticals (AGIO)? Wall Street Analysts Think 26.43%
Zacks via Yahoo Finance· 5 days agoThe mean of analysts' price targets for Agios Pharmaceuticals (AGIO) points to a 26.4% upside in the...